vs

Side-by-side financial comparison of LSI INDUSTRIES INC (LYTS) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

LSI INDUSTRIES INC is the larger business by last-quarter revenue ($143.9M vs $127.1M, roughly 1.1× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -4.4%). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 2.1%).

LSI Logic Corporation was an American ASIC and EDA company founded in Santa Clara, California. The company designed and sold semiconductors and software that accelerated storage and networking in data centers, mobile networks and client computing.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

LYTS vs ZLAB — Head-to-Head

Bigger by revenue
LYTS
LYTS
1.1× larger
LYTS
$143.9M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+21.5% gap
ZLAB
17.1%
-4.4%
LYTS
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
2.1%
LYTS

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
LYTS
LYTS
ZLAB
ZLAB
Revenue
$143.9M
$127.1M
Net Profit
$2.0M
Gross Margin
51.0%
Operating Margin
-54.6%
Net Margin
1.4%
Revenue YoY
-4.4%
17.1%
Net Profit YoY
-4.8%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LYTS
LYTS
ZLAB
ZLAB
Q3 26
$143.9M
Q1 26
$143.9M
Q4 25
$147.0M
$127.1M
Q3 25
$157.2M
$115.4M
Q2 25
$155.1M
$109.1M
Q1 25
$132.5M
$105.7M
Q4 24
$147.7M
$108.5M
Q3 24
$138.1M
$101.8M
Net Profit
LYTS
LYTS
ZLAB
ZLAB
Q3 26
$2.0M
Q1 26
$2.0M
Q4 25
$6.3M
Q3 25
$7.3M
$-36.0M
Q2 25
$8.2M
$-40.7M
Q1 25
$3.9M
$-48.4M
Q4 24
$5.6M
Q3 24
$6.7M
$-41.7M
Gross Margin
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
25.5%
51.0%
Q3 25
25.6%
59.5%
Q2 25
26.1%
60.6%
Q1 25
24.8%
63.6%
Q4 24
23.6%
61.5%
Q3 24
24.4%
64.1%
Operating Margin
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
6.0%
-54.6%
Q3 25
7.0%
-42.3%
Q2 25
7.7%
-50.3%
Q1 25
4.7%
-53.3%
Q4 24
5.7%
-62.6%
Q3 24
6.6%
-66.6%
Net Margin
LYTS
LYTS
ZLAB
ZLAB
Q3 26
1.4%
Q1 26
1.4%
Q4 25
4.3%
Q3 25
4.6%
-31.2%
Q2 25
5.3%
-37.3%
Q1 25
2.9%
-45.8%
Q4 24
3.8%
Q3 24
4.8%
-40.9%
EPS (diluted)
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
$0.20
$-0.05
Q3 25
$0.23
$-0.03
Q2 25
$0.26
$-0.04
Q1 25
$0.13
$-0.04
Q4 24
$0.18
$-0.09
Q3 24
$0.22
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LYTS
LYTS
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$689.6M
Total DebtLower is stronger
$261.0M
Stockholders' EquityBook value
$352.8M
$715.5M
Total Assets
$800.5M
$1.2B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
$6.4M
$689.6M
Q3 25
$7.1M
$717.2M
Q2 25
$3.5M
$732.2M
Q1 25
$4.3M
$757.3M
Q4 24
$4.7M
$779.7M
Q3 24
$7.0M
$616.1M
Total Debt
LYTS
LYTS
ZLAB
ZLAB
Q3 26
$261.0M
Q1 26
$261.0M
Q4 25
$27.9M
Q3 25
$50.7M
Q2 25
$48.6M
Q1 25
$55.4M
Q4 24
$38.2M
Q3 24
$47.7M
Stockholders' Equity
LYTS
LYTS
ZLAB
ZLAB
Q3 26
$352.8M
Q1 26
$352.8M
Q4 25
$248.1M
$715.5M
Q3 25
$241.3M
$759.9M
Q2 25
$230.7M
$791.7M
Q1 25
$221.7M
$810.8M
Q4 24
$217.1M
$840.9M
Q3 24
$211.2M
$667.7M
Total Assets
LYTS
LYTS
ZLAB
ZLAB
Q3 26
$800.5M
Q1 26
$800.5M
Q4 25
$396.3M
$1.2B
Q3 25
$404.9M
$1.2B
Q2 25
$396.4M
$1.2B
Q1 25
$384.6M
$1.2B
Q4 24
$344.5M
$1.2B
Q3 24
$349.5M
$985.3M
Debt / Equity
LYTS
LYTS
ZLAB
ZLAB
Q3 26
0.74×
Q1 26
0.74×
Q4 25
0.11×
Q3 25
0.21×
Q2 25
0.21×
Q1 25
0.25×
Q4 24
0.18×
Q3 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LYTS
LYTS
ZLAB
ZLAB
Operating Cash FlowLast quarter
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
$25.0M
$-26.0M
Q3 25
$676.0K
$-32.0M
Q2 25
$9.5M
$-31.0M
Q1 25
$6.9M
$-61.7M
Q4 24
$9.9M
$-55.8M
Q3 24
$11.8M
$-26.8M
Free Cash Flow
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
$23.3M
$-26.7M
Q3 25
$-291.0K
$-35.0M
Q2 25
$8.5M
$-33.9M
Q1 25
$6.2M
$-63.2M
Q4 24
$8.8M
$-58.4M
Q3 24
$11.1M
$-28.2M
FCF Margin
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
15.8%
-21.0%
Q3 25
-0.2%
-30.4%
Q2 25
5.5%
-31.1%
Q1 25
4.7%
-59.9%
Q4 24
6.0%
-53.8%
Q3 24
8.0%
-27.7%
Capex Intensity
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
1.1%
0.5%
Q3 25
0.6%
2.6%
Q2 25
0.6%
2.6%
Q1 25
0.5%
1.5%
Q4 24
0.7%
2.4%
Q3 24
0.5%
1.3%
Cash Conversion
LYTS
LYTS
ZLAB
ZLAB
Q3 26
Q1 26
Q4 25
3.94×
Q3 25
0.09×
Q2 25
1.16×
Q1 25
1.77×
Q4 24
1.75×
Q3 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LYTS
LYTS

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons